Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS3W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -1.1 %
2W -1.5 %
1M 5.0 %
3M 9.0 %
6M 23.6 %
9M 24.8 %
1Y -26.0 %
Alpha
-34.6%
Beta
0.45
sharpe-R
-0.51
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:01:09
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -50.18%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 8.06% -9.54%
UTMD Utah Medical Products, Inc. Sell -3.27% 0.42%
AADI Aadi Bioscience, Inc. Sell -2.94% 10.38%
CARA Cara Therapeutics, Inc. Sell -5.27% -7.44%
ANGO AngioDynamics, Inc. Sell -3.28% 6.34%
The percentage of cash held in the portfolio is: 106.71%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 8.12% -9.29%
UTMD Utah Medical Products, Inc. Sell -3.33% -0.75%
AADI Aadi Bioscience, Inc. Sell -2.98% 9.69%
CARA Cara Therapeutics, Inc. Sell -5.71% -15.7%
ANGO AngioDynamics, Inc. Sell -3.36% 4.62%
The percentage of cash held in the portfolio is: 107.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
HROW Buy All 1.18%
Assets Rebalanced
None
2025-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.95% -10.78%
HROW Harrow Health, Inc. Sell -4.63% 7.28%
UTMD Utah Medical Products, Inc. Sell -3.24% 1.26%
AADI Aadi Bioscience, Inc. Sell -3.05% 7.27%
CARA Cara Therapeutics, Inc. Sell -5.32% -8.47%
ANGO AngioDynamics, Inc. Sell -3.32% 5.25%
The percentage of cash held in the portfolio is: 111.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Buy All 9.52%
Assets Rebalanced
None
2025-02-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 8.69% -2.23%
FGEN FibroGen, Inc. Sell -4.28% 1.19%
HROW Harrow Health, Inc. Sell -4.94% 0.9%
UTMD Utah Medical Products, Inc. Sell -3.23% 1.44%
AADI Aadi Bioscience, Inc. Sell -3.02% 7.96%
CARA Cara Therapeutics, Inc. Sell -5.1% -4.13%
ANGO AngioDynamics, Inc. Sell -3.44% 1.72%
The percentage of cash held in the portfolio is: 115.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All -15.67%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.94% -8.62%
RGNX REGENXBIO Inc. Buy 8.96% 1.73%
FGEN FibroGen, Inc. Sell -4.29% 0.2%
HROW Harrow Health, Inc. Sell -4.74% 3.96%
UTMD Utah Medical Products, Inc. Sell -3.17% 2.37%
AADI Aadi Bioscience, Inc. Sell -3.11% 4.15%
CARA Cara Therapeutics, Inc. Sell -5.01% -3.31%
ANGO AngioDynamics, Inc. Sell -3.47% 0%
The percentage of cash held in the portfolio is: 107.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -7.77%
Assets Rebalanced
None
2025-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 7.37% -2.35%
BLFS BioLife Solutions, Inc. Buy 9.6% -7.46%
RGNX REGENXBIO Inc. Buy 9.15% 4.46%
FGEN FibroGen, Inc. Sell -4.24% 0.79%
HROW Harrow Health, Inc. Sell -4.72% 3.87%
UTMD Utah Medical Products, Inc. Sell -3.16% 2.3%
AADI Aadi Bioscience, Inc. Sell -3.16% 2.08%
CARA Cara Therapeutics, Inc. Sell -5.11% -5.79%
ANGO AngioDynamics, Inc. Sell -3.47% -0.54%
The percentage of cash held in the portfolio is: 97.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All 6.61%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 7.74% 8.11%
AGEN Agenus Inc. Buy 7.64% 1.83%
BLFS BioLife Solutions, Inc. Buy 9.74% -5.58%
RGNX REGENXBIO Inc. Buy 9.09% 4.46%
FGEN FibroGen, Inc. Sell -4.27% -0.6%
HROW Harrow Health, Inc. Sell -4.67% 4.34%
UTMD Utah Medical Products, Inc. Sell -3.14% 2.14%
AADI Aadi Bioscience, Inc. Sell -3.22% -0.35%
CARA Cara Therapeutics, Inc. Sell -4.99% -4.13%
ANGO AngioDynamics, Inc. Sell -3.38% 1.36%
The percentage of cash held in the portfolio is: 89.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All -0.14%
MDXG Sell All -3.17%
AXSM Sell All 21.6%
CERS Sell All 1.62%
ATXS Sell All -2.31%
DNLI Sell All 9.72%
NVRO Sell All 18.4%
LGND Sell All 6.37%
Assets Rebalanced
None
2025-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 7.2% -0.64%
MDXG MiMedx Group, Inc. Buy 7.03% -3.06%
AXSM Axsome Therapeutics, Inc. Buy 8.72% 20.45%
CERS Cerus Corporation Buy 6.14% 0.54%
ATXS Astria Therapeutics, Inc. Buy 7% -3.47%
DNLI Denali Therapeutics Inc. Buy 7.59% 6.93%
NVRO Nevro Corp. Buy 7.01% 20.99%
LGND Ligand Pharmaceuticals Incorporated Buy 6.72% 6.33%
ORGO Organogenesis Holdings Inc. Buy 7.54% 4.5%
AGEN Agenus Inc. Buy 6.91% -8.62%
BLFS BioLife Solutions, Inc. Buy 9.67% -6.96%
RGNX REGENXBIO Inc. Buy 9.17% 4.46%
FGEN FibroGen, Inc. Sell -3.93% 8.1%
HROW Harrow Health, Inc. Sell -4.7% 4.52%
UTMD Utah Medical Products, Inc. Sell -3.17% 2.17%
AADI Aadi Bioscience, Inc. Sell -3.06% 5.54%
CARA Cara Therapeutics, Inc. Sell -4.91% -1.45%
ANGO AngioDynamics, Inc. Sell -3.44% 0.54%
The percentage of cash held in the portfolio is: 32.5%
New Assets Added
None
Assets Removed
Asset Action Perf %
GERN Buy All 1.02%
MDRX Buy All 47.11%
ACRS Sell All 0.4%
NUTX Sell All 52.16%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 7.43% -4%
NUTX Nutex Health Inc. Buy 8.31% 53.16%
MD Pediatrix Medical Group, Inc. Buy 7.38% -0.57%
MDXG MiMedx Group, Inc. Buy 7.18% -3.17%
AXSM Axsome Therapeutics, Inc. Buy 8.49% 14.59%
CERS Cerus Corporation Buy 6.09% -2.7%
ATXS Astria Therapeutics, Inc. Buy 7.08% -4.62%
DNLI Denali Therapeutics Inc. Buy 7.38% 1.58%
NVRO Nevro Corp. Buy 6.97% 17.45%
LGND Ligand Pharmaceuticals Incorporated Buy 6.73% 4.06%
ORGO Organogenesis Holdings Inc. Buy 7.56% 2.4%
AGEN Agenus Inc. Buy 7.1% -8.36%
BLFS BioLife Solutions, Inc. Buy 10.01% -5.94%
RGNX REGENXBIO Inc. Buy 8.71% -3.1%
GERN Geron Corporation Sell -3.66% 3.06%
MDRX Allscripts Healthcare Solutions, Inc. Sell -2.75% 44.44%
FGEN FibroGen, Inc. Sell -4.14% 5.56%
HROW Harrow Health, Inc. Sell -4.65% 7.62%
UTMD Utah Medical Products, Inc. Sell -3.24% 2.27%
AADI Aadi Bioscience, Inc. Sell -3.14% 5.19%
CARA Cara Therapeutics, Inc. Sell -4.89% 1.24%
ANGO AngioDynamics, Inc. Sell -3.54% 0%
The percentage of cash held in the portfolio is: 23.59%
New Assets Added
  • ANGO
Assets Removed
Asset Action Perf %
AVXL Buy All 18.1%
INSM Sell All 12.98%
AXGN Sell All -1.81%
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 6.88% 11.1%
AXGN AxoGen, Inc. Buy 6.72% -0.22%
ACRS Aclaris Therapeutics, Inc. Buy 7.5% -0.8%
NUTX Nutex Health Inc. Buy 7.89% 48.84%
MD Pediatrix Medical Group, Inc. Buy 7.23% -0.14%
MDXG MiMedx Group, Inc. Buy 7.14% -1.36%
AXSM Axsome Therapeutics, Inc. Buy 8.21% 13.56%
CERS Cerus Corporation Buy 6.17% 1.08%
ATXS Astria Therapeutics, Inc. Buy 7.31% 0.9%
DNLI Denali Therapeutics Inc. Buy 7.69% 8.37%
NVRO Nevro Corp. Buy 6.92% 19.58%
LGND Ligand Pharmaceuticals Incorporated Buy 6.68% 5.69%
ORGO Organogenesis Holdings Inc. Buy 7.97% 10.51%
AGEN Agenus Inc. Buy 7.5% -0.78%
SIGA SIGA Technologies, Inc. Buy 7.39% -6.42%
BLFS BioLife Solutions, Inc. Buy 10.03% -3.5%
RGNX REGENXBIO Inc. Buy 8.77% 0%
AVXL Anavex Life Sciences Corp. Sell -3.4% 12.13%
GERN Geron Corporation Sell -3.59% 2.38%
MDRX Allscripts Healthcare Solutions, Inc. Sell -2.93% 39.33%
FGEN FibroGen, Inc. Sell -4.11% 3.97%
HROW Harrow Health, Inc. Sell -4.68% 4.86%
UTMD Utah Medical Products, Inc. Sell -3.23% 0.13%
AADI Aadi Bioscience, Inc. Sell -3.22% 0.35%
CARA Cara Therapeutics, Inc. Sell -4.83% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
  • RGNX
Assets Removed
Asset Action Perf %
VKTX Buy All 16.69%
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
INSM Insmed Incorporated Buy 7.08% 13.16%
AXGN AxoGen, Inc. Buy 6.82% 0.33%
ACRS Aclaris Therapeutics, Inc. Buy 7.21% -5.6%
NUTX Nutex Health Inc. Buy 7.49% 39.94%
MD Pediatrix Medical Group, Inc. Buy 7.42% 1.36%
MDXG MiMedx Group, Inc. Buy 7.51% 2.61%
AXSM Axsome Therapeutics, Inc. Buy 8.2% 12.15%
CERS Cerus Corporation Buy 6.47% 4.86%
ATXS Astria Therapeutics, Inc. Buy 7.01% -4.24%
DNLI Denali Therapeutics Inc. Buy 7.8% 8.88%
NVRO Nevro Corp. Buy 6.98% 19.34%
LGND Ligand Pharmaceuticals Incorporated Buy 6.88% 7.83%
ORGO Organogenesis Holdings Inc. Buy 8.32% 14.11%
AGEN Agenus Inc. Buy 7.2% -5.74%
SIGA SIGA Technologies, Inc. Buy 7.82% -2.03%
TGTX TG Therapeutics, Inc. Buy 7.3% 4.54%
BLFS BioLife Solutions, Inc. Buy 10.5% 0%
VKTX Viking Therapeutics, Inc. Sell -2.99% 14.96%
AVXL Anavex Life Sciences Corp. Sell -3.6% 8.06%
GERN Geron Corporation Sell -3.66% 1.7%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.13% 15.44%
FGEN FibroGen, Inc. Sell -4.12% 4.76%
HROW Harrow Health, Inc. Sell -4.98% -0.19%
UTMD Utah Medical Products, Inc. Sell -3.27% 0%
AADI Aadi Bioscience, Inc. Sell -3.27% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • UTMD
  • AADI
  • BLFS
Assets Removed
Asset Action Perf %
ORMP Buy All 5.46%
AORT Sell All 3.27%
Assets Rebalanced
None
2025-01-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.29% 2.68%
INSM Insmed Incorporated Buy 7.2% 13.83%
AXGN AxoGen, Inc. Buy 6.94% 0.88%
ACRS Aclaris Therapeutics, Inc. Buy 7.38% -4.4%
NUTX Nutex Health Inc. Buy 7.24% 33.72%
MD Pediatrix Medical Group, Inc. Buy 7.64% 3.29%
MDXG MiMedx Group, Inc. Buy 7.6% 2.72%
AXSM Axsome Therapeutics, Inc. Buy 8.08% 9.29%
CERS Cerus Corporation Buy 7.15% 14.59%
ATXS Astria Therapeutics, Inc. Buy 7.11% -3.85%
DNLI Denali Therapeutics Inc. Buy 7.92% 9.3%
NVRO Nevro Corp. Buy 6.96% 17.69%
LGND Ligand Pharmaceuticals Incorporated Buy 6.91% 7.1%
ORGO Organogenesis Holdings Inc. Buy 7.88% 6.91%
AGEN Agenus Inc. Buy 7.18% -7.05%
SIGA SIGA Technologies, Inc. Buy 7.83% -2.97%
TGTX TG Therapeutics, Inc. Buy 7.39% 4.79%
ORMP Oramed Pharmaceuticals Inc. Sell -3.3% 5.46%
VKTX Viking Therapeutics, Inc. Sell -3.1% 12.69%
AVXL Anavex Life Sciences Corp. Sell -3.71% 6.07%
GERN Geron Corporation Sell -3.84% -2.04%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.39% 11.11%
FGEN FibroGen, Inc. Sell -4.25% 2.78%
HROW Harrow Health, Inc. Sell -5.09% -1.27%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Buy All 25.71%
Assets Rebalanced
Asset Action Weight
AXGN Sell -0.84%
TGTX Sell -5.51%
AXSM Buy 0.24%
DNLI Buy 0.36%
SIGA Buy 0.47%
ORGO Buy 1.03%
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.22% 1.36%
AXGN AxoGen, Inc. Buy 7.6% -1.75%
INSM Insmed Incorporated Buy 7.14% 12.62%
ACRS Aclaris Therapeutics, Inc. Buy 7.59% -2%
NUTX Nutex Health Inc. Buy 6.87% 26.44%
MD Pediatrix Medical Group, Inc. Buy 7.78% 4.86%
MDXG MiMedx Group, Inc. Buy 7.33% -1.25%
ATXS Astria Therapeutics, Inc. Buy 7.19% -3.21%
AXSM Axsome Therapeutics, Inc. Buy 7.19% 9.54%
LGND Ligand Pharmaceuticals Incorporated Buy 6.88% 6.35%
DNLI Denali Therapeutics Inc. Buy 6.97% 7.86%
CERS Cerus Corporation Buy 7.27% 16.22%
NVRO Nevro Corp. Buy 7.01% 18.16%
ORGO Organogenesis Holdings Inc. Buy 7.21% 12.31%
AGEN Agenus Inc. Buy 7.28% -6.01%
SIGA SIGA Technologies, Inc. Buy 7.1% -0.78%
TGTX TG Therapeutics, Inc. Buy 12.35% 0%
FATE Fate Therapeutics, Inc. Sell -2.75% 21.71%
ORMP Oramed Pharmaceuticals Inc. Sell -3.3% 5.88%
VKTX Viking Therapeutics, Inc. Sell -3.03% 14.88%
AVXL Anavex Life Sciences Corp. Sell -3.69% 6.92%
GERN Geron Corporation Sell -3.8% -0.68%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.14% 16.33%
FGEN FibroGen, Inc. Sell -4.24% 3.17%
HROW Harrow Health, Inc. Sell -5.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HROW
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
Assets Rebalanced
None
2025-01-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.29% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 7.81% -10.26%
AXGN AxoGen, Inc. Buy 7.76% -0.6%
INSM Insmed Incorporated Buy 7.29% 13.85%
ACRS Aclaris Therapeutics, Inc. Buy 7.85% 0.4%
NUTX Nutex Health Inc. Buy 7.29% 32.94%
MD Pediatrix Medical Group, Inc. Buy 7.66% 2.29%
MDXG MiMedx Group, Inc. Buy 7.47% -0.34%
ATXS Astria Therapeutics, Inc. Buy 7.13% -4.88%
AXSM Axsome Therapeutics, Inc. Buy 7.29% 9.98%
LGND Ligand Pharmaceuticals Incorporated Buy 6.81% 4.31%
DNLI Denali Therapeutics Inc. Buy 6.74% 3.35%
CERS Cerus Corporation Buy 6.73% 6.49%
NVRO Nevro Corp. Buy 7.29% 21.7%
ORGO Organogenesis Holdings Inc. Buy 6.93% 6.91%
AGEN Agenus Inc. Buy 7.29% -6.79%
SIGA SIGA Technologies, Inc. Buy 7.29% 0.94%
FATE Fate Therapeutics, Inc. Sell -2.69% 24%
ORMP Oramed Pharmaceuticals Inc. Sell -3.37% 4.62%
VKTX Viking Therapeutics, Inc. Sell -3.16% 12.24%
AVXL Anavex Life Sciences Corp. Sell -3.98% 0.57%
GERN Geron Corporation Sell -3.9% -2.38%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.33% 13.33%
FGEN FibroGen, Inc. Sell -4.47% -0.99%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
TGTX Buy All -11.64%
Assets Rebalanced
Asset Action Weight
DNLI Sell -1.01%
LGND Sell -1%
CERS Sell -1.25%
AXSM Sell -0.95%
INSM Sell -1.6%
NVRO Sell -1.83%
NUTX Sell -3.11%
ESPR Buy 0.93%
AORT Buy 1.02%
AGEN Buy 1.34%
SIGA Buy 2.95%
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 6.34% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 6.71% -5.98%
AXGN AxoGen, Inc. Buy 8.14% 3.51%
INSM Insmed Incorporated Buy 8.95% 13.81%
NUTX Nutex Health Inc. Buy 9.38% 19.09%
ACRS Aclaris Therapeutics, Inc. Buy 8.19% 4%
MD Pediatrix Medical Group, Inc. Buy 7.58% 0.5%
MDXG MiMedx Group, Inc. Buy 7.69% 1.93%
NVRO Nevro Corp. Buy 8.72% 15.57%
LGND Ligand Pharmaceuticals Incorporated Buy 7.93% 5.06%
AXSM Axsome Therapeutics, Inc. Buy 8.23% 9.09%
CERS Cerus Corporation Buy 7.38% -2.16%
DNLI Denali Therapeutics Inc. Buy 8.18% 8.42%
ATXS Astria Therapeutics, Inc. Buy 7.26% -3.72%
ORGO Organogenesis Holdings Inc. Buy 6.86% 5.11%
AGEN Agenus Inc. Buy 6.14% -4.44%
SIGA SIGA Technologies, Inc. Buy 4.33% 0%
TGTX TG Therapeutics, Inc. Sell -3.74% -4.07%
FATE Fate Therapeutics, Inc. Sell -2.73% 23.43%
ORMP Oramed Pharmaceuticals Inc. Sell -3.46% 2.94%
VKTX Viking Therapeutics, Inc. Sell -3.14% 13.38%
AVXL Anavex Life Sciences Corp. Sell -3.82% 5.31%
GERN Geron Corporation Sell -3.9% -1.7%
MDRX Allscripts Healthcare Solutions, Inc. Sell -4.76% 5.33%
FGEN FibroGen, Inc. Sell -4.45% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • FGEN
  • SIGA
Assets Removed
Asset Action Perf %
EBS Buy All -15.52%
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 4.7% -17.94%
AORT Artivion, Inc. Buy 6.5% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 6.55% -8.12%
AXGN AxoGen, Inc. Buy 8.17% 3.95%
INSM Insmed Incorporated Buy 8.75% 11.34%
NUTX Nutex Health Inc. Buy 9.46% 20.31%
ACRS Aclaris Therapeutics, Inc. Buy 8.18% 4%
MD Pediatrix Medical Group, Inc. Buy 7.54% 0%
MDXG MiMedx Group, Inc. Buy 7.81% 3.63%
NVRO Nevro Corp. Buy 8.32% 10.38%
LGND Ligand Pharmaceuticals Incorporated Buy 8.02% 6.42%
AXSM Axsome Therapeutics, Inc. Buy 7.73% 2.59%
CERS Cerus Corporation Buy 7.54% 0%
DNLI Denali Therapeutics Inc. Buy 8.08% 7.16%
ATXS Astria Therapeutics, Inc. Buy 7.32% -2.82%
ORGO Organogenesis Holdings Inc. Buy 6.91% 6.01%
AGEN Agenus Inc. Buy 6.42% 0%
TGTX TG Therapeutics, Inc. Sell -3.83% -6.64%
FATE Fate Therapeutics, Inc. Sell -2.69% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.44% 3.36%
VKTX Viking Therapeutics, Inc. Sell -3.03% 16.38%
AVXL Anavex Life Sciences Corp. Sell -3.76% 6.64%
EBS Emergent BioSolutions Inc. Sell -4.37% -8.61%
GERN Geron Corporation Sell -3.86% -0.68%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.03% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • AGEN
Assets Removed
Asset Action Perf %
APLS Buy All -9.8%
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.88% 0.47%
BLUE bluebird bio, Inc. Buy 4.87% -16.73%
AORT Artivion, Inc. Buy 6.56% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 7.03% -3.42%
AXGN AxoGen, Inc. Buy 8.1% 0.99%
INSM Insmed Incorporated Buy 8.47% 5.54%
NUTX Nutex Health Inc. Buy 9.5% 18.31%
ACRS Aclaris Therapeutics, Inc. Buy 8.07% 0.4%
MD Pediatrix Medical Group, Inc. Buy 7.57% -1.64%
MDXG MiMedx Group, Inc. Buy 7.92% 2.95%
NVRO Nevro Corp. Buy 8.17% 6.13%
LGND Ligand Pharmaceuticals Incorporated Buy 7.75% 0.73%
AXSM Axsome Therapeutics, Inc. Buy 7.69% -0.06%
CERS Cerus Corporation Buy 7.57% -1.62%
DNLI Denali Therapeutics Inc. Buy 7.76% 0.79%
ATXS Astria Therapeutics, Inc. Buy 7.66% -0.51%
ORGO Organogenesis Holdings Inc. Buy 6.66% 0%
TGTX TG Therapeutics, Inc. Sell -3.81% -4.07%
FATE Fate Therapeutics, Inc. Sell -2.6% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.54% 2.52%
APLS Apellis Pharmaceuticals, Inc. Sell -4% -8.35%
VKTX Viking Therapeutics, Inc. Sell -3.06% 17.17%
AVXL Anavex Life Sciences Corp. Sell -3.96% 3.79%
EBS Emergent BioSolutions Inc. Sell -4.36% -5.95%
GERN Geron Corporation Sell -3.89% 0.68%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ORGO
Assets Removed
Asset Action Perf %
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.82% -3.76%
BLUE bluebird bio, Inc. Buy 5.05% -16.43%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.02% -4.51%
AORT Artivion, Inc. Buy 6.53% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 7.11% -5.56%
AXGN AxoGen, Inc. Buy 8.51% 2.63%
INSM Insmed Incorporated Buy 8.45% 1.84%
NUTX Nutex Health Inc. Buy 8.49% 2.16%
ACRS Aclaris Therapeutics, Inc. Buy 8.34% 0.4%
MD Pediatrix Medical Group, Inc. Buy 7.96% 0%
MDXG MiMedx Group, Inc. Buy 7.96% 0%
NVRO Nevro Corp. Buy 7.96% 0%
LGND Ligand Pharmaceuticals Incorporated Buy 7.96% 0%
AXSM Axsome Therapeutics, Inc. Buy 7.96% 0%
CERS Cerus Corporation Buy 7.96% 0%
DNLI Denali Therapeutics Inc. Buy 7.96% 0%
ATXS Astria Therapeutics, Inc. Buy 7.96% 0%
TGTX TG Therapeutics, Inc. Sell -4.08% -7.79%
FATE Fate Therapeutics, Inc. Sell -2.84% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.69% 1.68%
APLS Apellis Pharmaceuticals, Inc. Sell -4.04% -5.79%
VKTX Viking Therapeutics, Inc. Sell -3.39% 11.32%
AVXL Anavex Life Sciences Corp. Sell -4.57% -7.39%
EBS Emergent BioSolutions Inc. Sell -4.3% -1.17%
GERN Geron Corporation Sell -4.14% -2.38%
The percentage of cash held in the portfolio is: 3.07%
New Assets Added
  • MD
  • MDXG
  • NVRO
  • LGND
  • AXSM
  • CERS
  • DNLI
  • ATXS
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.78% -4.19%
BLUE bluebird bio, Inc. Buy 4.87% -19.25%
MDRX Allscripts Healthcare Solutions, Inc. Buy 5.86% -6.67%
AORT Artivion, Inc. Buy 6.43% -1.82%
ARDX Ardelyx, Inc. Buy 6.89% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 7.18% -4.27%
AXGN AxoGen, Inc. Buy 8.27% -0.05%
INSM Insmed Incorporated Buy 8.19% -0.93%
NUTX Nutex Health Inc. Buy 8.28% 0%
ACRS Aclaris Therapeutics, Inc. Buy 8.28% 0%
TGTX TG Therapeutics, Inc. Sell -4.01% -6.21%
FATE Fate Therapeutics, Inc. Sell -2.68% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.71% 0.84%
APLS Apellis Pharmaceuticals, Inc. Sell -3.84% -0.91%
VKTX Viking Therapeutics, Inc. Sell -3.29% 13.69%
AVXL Anavex Life Sciences Corp. Sell -4.21% 0.76%
EBS Emergent BioSolutions Inc. Sell -4.22% 0.53%
GERN Geron Corporation Sell -4.03% 0%
The percentage of cash held in the portfolio is: 59.97%
New Assets Added
  • GERN
  • NUTX
  • ACRS
Assets Removed
Asset Action Perf %
NUTX Buy All -3.63%
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.8% -3.07%
BLUE bluebird bio, Inc. Buy 5.12% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.07% -2.56%
AORT Artivion, Inc. Buy 6.31% -2.94%
ARDX Ardelyx, Inc. Buy 7.16% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 7.25% -2.56%
AXGN AxoGen, Inc. Buy 8.21% 0%
INSM Insmed Incorporated Buy 8.21% 0%
TGTX TG Therapeutics, Inc. Sell -3.71% 1.18%
FATE Fate Therapeutics, Inc. Sell -2.75% 26.29%
ORMP Oramed Pharmaceuticals Inc. Sell -3.69% 0.84%
NUTX Nutex Health Inc. Sell -3.77% 0.39%
APLS Apellis Pharmaceuticals, Inc. Sell -3.94% -4.19%
VKTX Viking Therapeutics, Inc. Sell -3.74% 1.09%
AVXL Anavex Life Sciences Corp. Sell -4.21% 0%
EBS Emergent BioSolutions Inc. Sell -4.21% 0%
The percentage of cash held in the portfolio is: 75.87%
New Assets Added
  • AVXL
  • EBS
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.84% -3.63%
BLUE bluebird bio, Inc. Buy 5.17% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.15% -2.46%
AORT Artivion, Inc. Buy 6.5% -1.16%
ARDX Ardelyx, Inc. Buy 6.25% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 7.54% 0%
TGTX TG Therapeutics, Inc. Sell -3.91% -3.14%
FATE Fate Therapeutics, Inc. Sell -3.17% 16%
ORMP Oramed Pharmaceuticals Inc. Sell -3.78% -0.42%
NUTX Nutex Health Inc. Sell -3.83% 0%
APLS Apellis Pharmaceuticals, Inc. Sell -3.83% 0%
VKTX Viking Therapeutics, Inc. Sell -3.83% 0%
The percentage of cash held in the portfolio is: 84.9%
New Assets Added
  • NUTX
  • APLS
  • VKTX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 6.06% 0.36%
BLUE bluebird bio, Inc. Buy 5.15% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.14% -2.46%
AORT Artivion, Inc. Buy 6.56% 0%
ARDX Ardelyx, Inc. Buy 6.56% 0%
TGTX TG Therapeutics, Inc. Sell -3.89% -2.75%
FATE Fate Therapeutics, Inc. Sell -3.59% 4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 80.75%
New Assets Added
  • ORMP
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.97% -0.82%
BLUE bluebird bio, Inc. Buy 5.47% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 6.27% 0%
TGTX TG Therapeutics, Inc. Sell -3.77% 0%
FATE Fate Therapeutics, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 89.8%
New Assets Added
  • FATE
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 5.99% 0%
BLUE bluebird bio, Inc. Buy 5.99% 0%
TGTX TG Therapeutics, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 91.78%
New Assets Added
  • TGTX
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-12-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All NA
Assets Rebalanced
None
2024-12-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 7.99% 1.99%
The percentage of cash held in the portfolio is: 92.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Buy All 19.51%
ATEC Buy All 7.7%
NKTR Buy All 14.95%
Assets Rebalanced
None
2024-12-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 7.88% 0.58%
CUTR Cutera, Inc. Sell -3.37% 19.51%
ATEC Alphatec Holdings, Inc. Sell -3.81% 8.8%
NKTR Nektar Therapeutics Sell -3.52% 15.89%
The percentage of cash held in the portfolio is: 102.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Buy All 43.92%
Assets Rebalanced
None
2024-12-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 7.84% -0.58%
FATE Fate Therapeutics, Inc. Sell -2.18% 43.24%
CUTR Cutera, Inc. Sell -3.7% 12.2%
ATEC Alphatec Holdings, Inc. Sell -3.94% 6.5%
NKTR Nektar Therapeutics Sell -3.66% 13.08%
The percentage of cash held in the portfolio is: 105.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Buy All 48.02%
Assets Rebalanced
None
2024-12-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 8.05% 2.51%
IBRX ImmunityBio, Inc. Sell -2.04% 47.02%
FATE Fate Therapeutics, Inc. Sell -2.15% 43.92%
CUTR Cutera, Inc. Sell -3.58% 14.63%
ATEC Alphatec Holdings, Inc. Sell -3.71% 11.5%
NKTR Nektar Therapeutics Sell -3.68% 12.15%
The percentage of cash held in the portfolio is: 107.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Buy All -49.27%
Assets Rebalanced
None
2024-12-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 7.77% 0.52%
IBRX ImmunityBio, Inc. Sell -1.99% 47.42%
FATE Fate Therapeutics, Inc. Sell -2.15% 42.91%
CUTR Cutera, Inc. Sell -3.72% 9.76%
ATEC Alphatec Holdings, Inc. Sell -3.64% 11.8%
NKTR Nektar Therapeutics Sell -3.58% 13.08%
CARA Cara Therapeutics, Inc. Sell -3.34% 4.38%
The percentage of cash held in the portfolio is: 110.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
SEM Buy All 10.17%
Assets Rebalanced
None
2024-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 8.07% 3.88%
SEM Select Medical Holdings Corporation Sell -3.14% 6.04%
IBRX ImmunityBio, Inc. Sell -2.14% 43.85%
FATE Fate Therapeutics, Inc. Sell -2.41% 36.49%
CUTR Cutera, Inc. Sell -3.54% 14.63%
ATEC Alphatec Holdings, Inc. Sell -3.95% 4.8%
NKTR Nektar Therapeutics Sell -3.95% 4.67%
CARA Cara Therapeutics, Inc. Sell -3.2% 8.76%
The percentage of cash held in the portfolio is: 114.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 5.82%
MGNX Sell All -1.76%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.88% 4.2%
MGNX MacroGenics, Inc. Buy 5.66% 0.29%
PCRX Pacira BioSciences, Inc. Buy 8.35% 6.5%
SEM Select Medical Holdings Corporation Sell -3.26% 3.29%
IBRX ImmunityBio, Inc. Sell -2.4% 37.5%
FATE Fate Therapeutics, Inc. Sell -2.82% 26.35%
CUTR Cutera, Inc. Sell -3.67% 12.2%
ATEC Alphatec Holdings, Inc. Sell -4.05% 3.1%
NKTR Nektar Therapeutics Sell -3.99% 4.67%
CARA Cara Therapeutics, Inc. Sell -3.45% 2.55%
The percentage of cash held in the portfolio is: 103.75%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.06% 7.32%
MGNX MacroGenics, Inc. Buy 5.78% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 8.75% 23.55%
PCRX Pacira BioSciences, Inc. Buy 7.84% 0%
SEM Select Medical Holdings Corporation Sell -3.32% 1.43%
IBRX ImmunityBio, Inc. Sell -3.66% 4.76%
FATE Fate Therapeutics, Inc. Sell -3.51% 8.11%
CUTR Cutera, Inc. Sell -3.77% 9.76%
ATEC Alphatec Holdings, Inc. Sell -4.02% 3.9%
NKTR Nektar Therapeutics Sell -3.95% 5.61%
CARA Cara Therapeutics, Inc. Sell -3.77% -6.57%
The percentage of cash held in the portfolio is: 97.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
PACB Buy All -23.86%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.82% 4.6%
MGNX MacroGenics, Inc. Buy 5.72% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 8.25% 18.06%
RVNC Revance Therapeutics, Inc. Buy 7.73% 0%
PCRX Pacira BioSciences, Inc. Buy 7.73% 0%
SEM Select Medical Holdings Corporation Sell -3.35% -0.84%
PACB Pacific Biosciences of California, Inc. Sell -3.93% -18.18%
IBRX ImmunityBio, Inc. Sell -3.56% 5.95%
FATE Fate Therapeutics, Inc. Sell -3.26% 13.51%
CUTR Cutera, Inc. Sell -4.33% -4.88%
ATEC Alphatec Holdings, Inc. Sell -4.15% -0.5%
NKTR Nektar Therapeutics Sell -3.93% 4.67%
CARA Cara Therapeutics, Inc. Sell -3.49% 0%
The percentage of cash held in the portfolio is: 94.75%
New Assets Added
  • CARA
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.89% 6.13%
MGNX MacroGenics, Inc. Buy 5.62% 1.18%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.04% -0.31%
ESPR Esperion Therapeutics, Inc. Buy 7.3% 4.84%
SEM Select Medical Holdings Corporation Sell -3.35% -1.08%
PACB Pacific Biosciences of California, Inc. Sell -3.44% -3.98%
IBRX ImmunityBio, Inc. Sell -3.42% 9.52%
FATE Fate Therapeutics, Inc. Sell -3.34% 11.15%
CUTR Cutera, Inc. Sell -4.11% 0%
ATEC Alphatec Holdings, Inc. Sell -4.11% 0%
NKTR Nektar Therapeutics Sell -4.11% 0%
The percentage of cash held in the portfolio is: 101.03%
New Assets Added
  • CUTR
  • ATEC
  • NKTR
Assets Removed
Asset Action Perf %
OSUR Buy All 7.49%
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.07% 8.55%
MGNX MacroGenics, Inc. Buy 6.07% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.15% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 7.02% 0%
OSUR OraSure Technologies, Inc. Sell -3.97% 5.8%
SEM Select Medical Holdings Corporation Sell -3.45% -3.34%
PACB Pacific Biosciences of California, Inc. Sell -3.66% -9.66%
IBRX ImmunityBio, Inc. Sell -3.76% 1.39%
FATE Fate Therapeutics, Inc. Sell -3.79% 0%
The percentage of cash held in the portfolio is: 93.3%
New Assets Added
  • FATE
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.82% 3.98%
MGNX MacroGenics, Inc. Buy 5.91% 5.59%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.08% -0.46%
FATE Fate Therapeutics, Inc. Buy 6.11% 0%
OSUR OraSure Technologies, Inc. Sell -3.87% 8.21%
SEM Select Medical Holdings Corporation Sell -3.46% -3.73%
PACB Pacific Biosciences of California, Inc. Sell -3.62% -8.52%
IBRX ImmunityBio, Inc. Sell -3.81% 0%
The percentage of cash held in the portfolio is: 90.84%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
CUTR Buy All -25.64%
KIDS Buy All -1.01%
ITGR Sell All 2.73%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 21.34% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 5.8% 4.63%
MGNX MacroGenics, Inc. Buy 5.93% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.05% 0%
FATE Fate Therapeutics, Inc. Buy 6.05% 0%
CUTR Cutera, Inc. Sell -4.85% -17.95%
KIDS OrthoPediatrics Corp. Sell -4.06% 1.28%
OSUR OraSure Technologies, Inc. Sell -3.87% 7.25%
SEM Select Medical Holdings Corporation Sell -3.31% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.31% 0%
The percentage of cash held in the portfolio is: 74.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMPH Buy All NA
CHRS Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 9.66% 53.66%
ITGR Integer Holdings Corporation Buy 21.34% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 5.8% 4.63%
MGNX MacroGenics, Inc. Buy 5.93% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.05% 0%
FATE Fate Therapeutics, Inc. Buy 6.05% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.99% 1.91%
CUTR Cutera, Inc. Sell -4.85% -17.95%
KIDS OrthoPediatrics Corp. Sell -4.06% 1.28%
OSUR OraSure Technologies, Inc. Sell -3.87% 7.25%
SEM Select Medical Holdings Corporation Sell -3.31% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.31% 0%
The percentage of cash held in the portfolio is: 68.56%
New Assets Added
  • SEM
  • PACB
  • ARWR
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 9.81% 56.1%
ITGR Integer Holdings Corporation Buy 21.04% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 5.54% 0%
MGNX MacroGenics, Inc. Buy 5.54% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.91% 4.06%
CUTR Cutera, Inc. Sell -4.11% 0%
KIDS OrthoPediatrics Corp. Sell -4.14% -0.74%
OSUR OraSure Technologies, Inc. Sell -3.86% 7.49%
The percentage of cash held in the portfolio is: 74.08%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 9.27% 47.56%
ITGR Integer Holdings Corporation Buy 21.25% 2.57%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.94% 3.15%
CUTR Cutera, Inc. Sell -3.48% 15.38%
KIDS OrthoPediatrics Corp. Sell -4.25% -3.46%
OSUR OraSure Technologies, Inc. Sell -3.96% 5.07%
The percentage of cash held in the portfolio is: 85.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
CORT Sell All 17.92%
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 7.08% 14.94%
CHRS Coherus BioSciences, Inc. Buy 8.46% 32.93%
ITGR Integer Holdings Corporation Buy 21.2% 0.99%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.06% 1.37%
CUTR Cutera, Inc. Sell -3.42% 17.95%
KIDS OrthoPediatrics Corp. Sell -4.27% -2.41%
OSUR OraSure Technologies, Inc. Sell -3.96% 6.28%
The percentage of cash held in the portfolio is: 78.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Buy All 15.63%
Assets Rebalanced
None
2024-11-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 6.91% 11.71%
CHRS Coherus BioSciences, Inc. Buy 8.57% 34.15%
ITGR Integer Holdings Corporation Buy 20.93% -0.64%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4% 3.34%
CUTR Cutera, Inc. Sell -3.43% 17.95%
KIDS OrthoPediatrics Corp. Sell -4.3% -2.92%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.52% 15.9%
OSUR OraSure Technologies, Inc. Sell -3.95% 7%
The percentage of cash held in the portfolio is: 82.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATEC Sell All 30.06%
Assets Rebalanced
None
2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 7.5% 26.5%
CORT Corcept Therapeutics Incorporated Buy 6.93% 12.05%
CHRS Coherus BioSciences, Inc. Buy 8.57% 34.15%
ITGR Integer Holdings Corporation Buy 20.55% -2.48%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.96% 4.34%
CUTR Cutera, Inc. Sell -3.22% 23.08%
KIDS OrthoPediatrics Corp. Sell -4.15% 0.86%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.43% 17.98%
OSUR OraSure Technologies, Inc. Sell -3.91% 7.97%
The percentage of cash held in the portfolio is: 75.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
AZTA Buy All -4.74%
TNDM Buy All 1.47%
IRTC Sell All -9.45%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 7.36% 21.91%
IRTC iRhythm Technologies, Inc. Buy 6.17% -7.33%
CORT Corcept Therapeutics Incorporated Buy 6.83% 8.49%
CHRS Coherus BioSciences, Inc. Buy 6.52% 0.18%
ITGR Integer Holdings Corporation Buy 20.95% -2.37%
AMPH Amphastar Pharmaceuticals, Inc. Sell -3.99% 5.36%
CUTR Cutera, Inc. Sell -3.28% 23.08%
TNDM Tandem Diabetes Care, Inc. Sell -3.88% 8.92%
KIDS OrthoPediatrics Corp. Sell -4.03% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.62% 14.91%
OSUR OraSure Technologies, Inc. Sell -4.03% 6.76%
AZTA Azenta, Inc. Sell -3.9% 4.03%
The percentage of cash held in the portfolio is: 78.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All 5.23%
INCY Sell All -4.56%
MGNX Sell All -10.08%
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 6.19% 6%
INCY Incyte Corporation Buy 6.5% 4.11%
ATEC Alphatec Holdings, Inc. Buy 6.56% 8.54%
MGNX MacroGenics, Inc. Buy 5.49% -9.3%
IRTC iRhythm Technologies, Inc. Buy 6.29% -5.62%
CORT Corcept Therapeutics Incorporated Buy 6.63% 5.11%
CHRS Coherus BioSciences, Inc. Buy 6.21% -4.76%
ITGR Integer Holdings Corporation Buy 21.14% -1.63%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.04% 4.19%
CUTR Cutera, Inc. Sell -3.17% 25.64%
TNDM Tandem Diabetes Care, Inc. Sell -4.01% 6.01%
KIDS OrthoPediatrics Corp. Sell -3.78% 11.31%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.69% 13.55%
OSUR OraSure Technologies, Inc. Sell -3.92% 9.42%
AZTA Azenta, Inc. Sell -3.85% 5.3%
The percentage of cash held in the portfolio is: 61.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Buy All 29.76%
HCSG Sell All 2.56%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 6.7% 5.39%
NEOG Neogen Corporation Buy 6.01% 1.81%
INCY Incyte Corporation Buy 6.46% 2.62%
ATEC Alphatec Holdings, Inc. Buy 6.4% 4.84%
MGNX MacroGenics, Inc. Buy 5.64% -7.75%
IRTC iRhythm Technologies, Inc. Buy 6.65% -1.22%
CORT Corcept Therapeutics Incorporated Buy 6.59% 3.54%
CHRS Coherus BioSciences, Inc. Buy 5.97% -9.27%
ITGR Integer Holdings Corporation Buy 21.13% -2.62%
VERU Veru Inc. Sell -2.54% 30.95%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.12% 3.21%
CUTR Cutera, Inc. Sell -3.53% 17.95%
TNDM Tandem Diabetes Care, Inc. Sell -3.85% 10.65%
KIDS OrthoPediatrics Corp. Sell -3.84% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.71% 13.91%
OSUR OraSure Technologies, Inc. Sell -4.06% 7%
AZTA Azenta, Inc. Sell -4% 2.63%
The percentage of cash held in the portfolio is: 58.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 6.78% 8.95%
NEOG Neogen Corporation Buy 5.9% 2.09%
INCY Incyte Corporation Buy 6.48% 5.14%
ATEC Alphatec Holdings, Inc. Buy 6.64% 11.21%
MGNX MacroGenics, Inc. Buy 5.89% -1.55%
IRTC iRhythm Technologies, Inc. Buy 6.75% 2.46%
CORT Corcept Therapeutics Incorporated Buy 6.82% 9.45%
CHRS Coherus BioSciences, Inc. Buy 6.07% -5.73%
ITGR Integer Holdings Corporation Buy 20.94% -1.41%
RGEN Repligen Corporation Buy 6.76% -5.34%
VERU Veru Inc. Sell -2.7% 25%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.08% 2.23%
CUTR Cutera, Inc. Sell -3.57% 15.38%
TNDM Tandem Diabetes Care, Inc. Sell -3.94% 6.57%
KIDS OrthoPediatrics Corp. Sell -3.72% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.86% 8.49%
OSUR OraSure Technologies, Inc. Sell -4.12% 3.62%
AZTA Azenta, Inc. Sell -4.02% 0%
The percentage of cash held in the portfolio is: 50.96%
New Assets Added
  • AZTA
Assets Removed
Asset Action Perf %
COLL Buy All 11.77%
SAGE Sell All -15.03%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 6.76% 11.32%
NEOG Neogen Corporation Buy 5.96% 5.86%
INCY Incyte Corporation Buy 6.55% 8.86%
ATEC Alphatec Holdings, Inc. Buy 6.78% 16.31%
MGNX MacroGenics, Inc. Buy 5.69% -2.58%
IRTC iRhythm Technologies, Inc. Buy 6.88% 6.99%
CORT Corcept Therapeutics Incorporated Buy 6.86% 12.76%
SAGE Sage Therapeutics, Inc. Buy 5.7% -9.34%
CHRS Coherus BioSciences, Inc. Buy 5.97% -5%
ITGR Integer Holdings Corporation Buy 20.84% 0.58%
ALT Altimmune, Inc. Buy 7.17% 0.32%
RGEN Repligen Corporation Buy 6.97% 0%
COLL Collegium Pharmaceutical, Inc. Sell -2.77% 12.04%
VERU Veru Inc. Sell -2.6% 26.19%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.01% 1.32%
CUTR Cutera, Inc. Sell -3.8% 7.69%
TNDM Tandem Diabetes Care, Inc. Sell -3.99% 3.04%
KIDS OrthoPediatrics Corp. Sell -3.88% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.87% 5.78%
OSUR OraSure Technologies, Inc. Sell -4.08% 2.17%
The percentage of cash held in the portfolio is: 36.86%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
CDMO Sell All 17.76%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 7.31% 18.05%
HCSG Healthcare Services Group, Inc. Buy 6.87% 13.61%
NEOG Neogen Corporation Buy 6% 6.97%
INCY Incyte Corporation Buy 6.53% 8.99%
ATEC Alphatec Holdings, Inc. Buy 6.86% 18.22%
MGNX MacroGenics, Inc. Buy 6.16% 5.94%
IRTC iRhythm Technologies, Inc. Buy 6.85% 7.07%
CORT Corcept Therapeutics Incorporated Buy 6.99% 15.44%
CARA Cara Therapeutics, Inc. Buy 6.18% -1.16%
SAGE Sage Therapeutics, Inc. Buy 5.67% -9.34%
CHRS Coherus BioSciences, Inc. Buy 6.29% 0.49%
ITGR Integer Holdings Corporation Buy 20.66% 0.1%
ALT Altimmune, Inc. Buy 7.12% 0%
COLL Collegium Pharmaceutical, Inc. Sell -2.87% 8.45%
VERU Veru Inc. Sell -2.75% 21.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.19% -3.51%
CUTR Cutera, Inc. Sell -4.1% 0%
TNDM Tandem Diabetes Care, Inc. Sell -4.16% -1.63%
KIDS OrthoPediatrics Corp. Sell -3.83% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -3.94% 3.7%
OSUR OraSure Technologies, Inc. Sell -4.16% 0%
The percentage of cash held in the portfolio is: 30.49%
New Assets Added
  • OSUR
  • ALT
Assets Removed
Asset Action Perf %
DGX Buy All -3.71%
AVXL Sell All 36.25%
IBRX Sell All 17.58%
IOVA Sell All -12.15%
PTCT Sell All 13.48%
NUTX Sell All 51.33%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.68% 12.61%
NUTX Nutex Health Inc. Buy 7.57% 27.16%
CDMO Avid Bioservices, Inc. Buy 7.28% 18.34%
IBRX ImmunityBio, Inc. Buy 7.16% 32.3%
HCSG Healthcare Services Group, Inc. Buy 6.51% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 5.69% -3.99%
NEOG Neogen Corporation Buy 6.31% 13.18%
INCY Incyte Corporation Buy 6.71% 12.78%
ATEC Alphatec Holdings, Inc. Buy 6.91% 19.75%
AVXL Anavex Life Sciences Corp. Buy 7.73% 39.58%
MGNX MacroGenics, Inc. Buy 6.5% 12.4%
IRTC iRhythm Technologies, Inc. Buy 6.76% 6.19%
CORT Corcept Therapeutics Incorporated Buy 7.16% 19.06%
CARA Cara Therapeutics, Inc. Buy 6.13% -1.45%
SAGE Sage Therapeutics, Inc. Buy 6.21% -0.16%
CHRS Coherus BioSciences, Inc. Buy 6.18% -0.61%
ITGR Integer Holdings Corporation Buy 20.51% 0%
COLL Collegium Pharmaceutical, Inc. Sell -2.92% 6.27%
VERU Veru Inc. Sell -3.03% 13.1%
DGX Quest Diagnostics Incorporated Sell -3.56% -2.21%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.22% -4.82%
CUTR Cutera, Inc. Sell -4.07% 0%
TNDM Tandem Diabetes Care, Inc. Sell -4.07% 0%
KIDS OrthoPediatrics Corp. Sell -4.07% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -4.07% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
IART Sell All -0.52%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.71% 9.26%
NUTX Nutex Health Inc. Buy 7.17% 16.4%
CDMO Avid Bioservices, Inc. Buy 7.52% 18.15%
IBRX ImmunityBio, Inc. Buy 7.05% 25.89%
HCSG Healthcare Services Group, Inc. Buy 6.67% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 6.82% 11.33%
NEOG Neogen Corporation Buy 6.35% 10.04%
INCY Incyte Corporation Buy 6.86% 11.38%
ATEC Alphatec Holdings, Inc. Buy 7.16% 19.87%
AVXL Anavex Life Sciences Corp. Buy 6.61% 15.33%
MGNX MacroGenics, Inc. Buy 6.89% 15.25%
IRTC iRhythm Technologies, Inc. Buy 7.17% 8.99%
CORT Corcept Therapeutics Incorporated Buy 6.75% 8.47%
IART Integra LifeSciences Holdings Corporation Buy 6.45% 2.41%
CARA Cara Therapeutics, Inc. Buy 6.43% 0%
SAGE Sage Therapeutics, Inc. Buy 6.43% 0%
CHRS Coherus BioSciences, Inc. Buy 6.43% 0%
EVH Evolent Health, Inc. Sell -3.34% -5.95%
COLL Collegium Pharmaceutical, Inc. Sell -3.26% -1.17%
VERU Veru Inc. Sell -3.13% 13.1%
DGX Quest Diagnostics Incorporated Sell -3.61% -0.18%
AMPH Amphastar Pharmaceuticals, Inc. Sell -4.17% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
  • CARA
  • SAGE
  • CHRS
Assets Removed
Asset Action Perf %
CHRS Buy All -13.57%
NVRO Sell All -1.11%
QDEL Sell All -0.61%
VREX Sell All 17.93%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 6.55% 19.42%
PTCT PTC Therapeutics, Inc. Buy 6.77% 9.82%
NUTX Nutex Health Inc. Buy 6.77% 9.47%
CDMO Avid Bioservices, Inc. Buy 6.77% 5.98%
IBRX ImmunityBio, Inc. Buy 7.23% 28.74%
HCSG Healthcare Services Group, Inc. Buy 6.77% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 6.77% 10.06%
NEOG Neogen Corporation Buy 6.3% 8.93%
NVRO Nevro Corp. Buy 6.77% 7.04%
INCY Incyte Corporation Buy 6.77% 9.5%
ATEC Alphatec Holdings, Inc. Buy 6.77% 12.99%
AVXL Anavex Life Sciences Corp. Buy 6.77% 17.67%
MGNX MacroGenics, Inc. Buy 6.5% 8.27%
IRTC iRhythm Technologies, Inc. Buy 7.26% 9.9%
CORT Corcept Therapeutics Incorporated Buy 6.77% 8.33%
QDEL QuidelOrtho Corporation Buy 6.77% 2.23%
IART Integra LifeSciences Holdings Corporation Buy 6.77% 7.19%
EVH Evolent Health, Inc. Sell -3.37% -6.81%
COLL Collegium Pharmaceutical, Inc. Sell -3.25% -0.55%
VERU Veru Inc. Sell -3.18% 11.9%
CHRS Coherus BioSciences, Inc. Sell -3.62% -0.28%
DGX Quest Diagnostics Incorporated Sell -3.6% 0.47%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALGN Buy All -6.63%
BHVN Buy All -4.41%
SMTI Buy All -11.47%
Assets Rebalanced
Asset Action Weight
NEOG Sell -2.41%
NVRO Sell -2.06%
INCY Sell -2.26%
ATEC Sell -2.5%
AVXL Sell -2.88%
HCSG Sell -3.06%
IOVA Sell -3.2%
IRTC Buy 0.66%
CORT Buy 0.74%
PTCT Buy 0.79%
NUTX Buy 0.81%
IART Buy 0.87%
QDEL Buy 1.08%
CDMO Buy 1.96%
2024-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 6.45% 12.56%
NUTX Nutex Health Inc. Buy 5.73% 0.73%
PTCT PTC Therapeutics, Inc. Buy 5.91% 3.94%
CDMO Avid Bioservices, Inc. Buy 4.83% 1.74%
IBRX ImmunityBio, Inc. Buy 7.59% 29.22%
HCSG Healthcare Services Group, Inc. Buy 9.85% 4.02%
IOVA Iovance Biotherapeutics, Inc. Buy 10.01% 5.71%
NEOG Neogen Corporation Buy 8.76% 4.74%
NVRO Nevro Corp. Buy 8.88% 2.96%
INCY Incyte Corporation Buy 9.01% 4.53%
ATEC Alphatec Holdings, Inc. Buy 9.37% 9.3%
AVXL Anavex Life Sciences Corp. Buy 9.97% 16.31%
MGNX MacroGenics, Inc. Buy 6.11% -2.58%
IRTC iRhythm Technologies, Inc. Buy 6.19% 6.43%
CORT Corcept Therapeutics Incorporated Buy 6.06% 4.16%
QDEL QuidelOrtho Corporation Buy 5.88% 1.13%
IART Integra LifeSciences Holdings Corporation Buy 5.75% 0%
BHVN Biohaven Ltd. Sell -3.53% 0.12%
EVH Evolent Health, Inc. Sell -3.36% -1.64%
SMTI Sanara MedTech Inc. Sell -3.61% -6.97%
COLL Collegium Pharmaceutical, Inc. Sell -3.29% 2.59%
CHRS Coherus BioSciences, Inc. Sell -3.83% -1.25%
VERU Veru Inc. Sell -3.33% 11.9%
DGX Quest Diagnostics Incorporated Sell -3.74% 1.17%
ALGN Align Technology, Inc. Sell -3.69% -0.61%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IART
Assets Removed
None
Assets Rebalanced
None
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 6.49% 9.5%
NUTX Nutex Health Inc. Buy 5.46% -7.17%
PTCT PTC Therapeutics, Inc. Buy 6.04% 2.72%
CDMO Avid Bioservices, Inc. Buy 4.9% -0.19%
IBRX ImmunityBio, Inc. Buy 7.5% 23.52%
HCSG Healthcare Services Group, Inc. Buy 9.99% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 10.16% 3.72%
NEOG Neogen Corporation Buy 8.71% 0.63%
NVRO Nevro Corp. Buy 8.83% -0.93%
INCY Incyte Corporation Buy 9.14% 2.46%
ATEC Alphatec Holdings, Inc. Buy 9.45% 6.5%
AVXL Anavex Life Sciences Corp. Buy 9.78% 10.27%
MGNX MacroGenics, Inc. Buy 6.21% -4.39%
IRTC iRhythm Technologies, Inc. Buy 6.01% 0%
CORT Corcept Therapeutics Incorporated Buy 6.01% 0%
QDEL QuidelOrtho Corporation Buy 6.01% 0%
BHVN Biohaven Ltd. Sell -3.55% 2.78%
EVH Evolent Health, Inc. Sell -3.44% -0.73%
SMTI Sanara MedTech Inc. Sell -3.7% -6.02%
COLL Collegium Pharmaceutical, Inc. Sell -3.33% 4.63%
CHRS Coherus BioSciences, Inc. Sell -3.63% 7.2%
VERU Veru Inc. Sell -3.4% 13.1%
DGX Quest Diagnostics Incorporated Sell -3.87% 1.02%
ALGN Align Technology, Inc. Sell -3.79% 0.04%
The percentage of cash held in the portfolio is: 8.01%
New Assets Added
  • IRTC
  • CORT
  • QDEL
Assets Removed
Asset Action Perf %
ARWR Sell All 3.62%
VCEL Sell All 5.42%
AXSM Sell All -6.53%
VKTX Sell All -13.77%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.43% 0.67%
VCEL Vericel Corporation Buy 6.67% 4.51%
VREX Varex Imaging Corporation Buy 6.5% 9.09%
AXSM Axsome Therapeutics, Inc. Buy 5.67% -4.83%
NUTX Nutex Health Inc. Buy 5.38% -8.94%
PTCT PTC Therapeutics, Inc. Buy 6.08% 2.92%
CDMO Avid Bioservices, Inc. Buy 4.89% -0.87%
VKTX Viking Therapeutics, Inc. Buy 6.07% -0.46%
IBRX ImmunityBio, Inc. Buy 7.65% 25.42%
HCSG Healthcare Services Group, Inc. Buy 10.02% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 9.98% 1.45%
NEOG Neogen Corporation Buy 8.75% 0.7%
NVRO Nevro Corp. Buy 9.17% 2.41%
INCY Incyte Corporation Buy 9.22% 2.98%
ATEC Alphatec Holdings, Inc. Buy 9.2% 3.31%
AVXL Anavex Life Sciences Corp. Buy 9.2% 3.25%
MGNX MacroGenics, Inc. Buy 6.52% 0%
BHVN Biohaven Ltd. Sell -3.63% 1.15%
EVH Evolent Health, Inc. Sell -3.47% -1.16%
SMTI Sanara MedTech Inc. Sell -3.73% -6.21%
COLL Collegium Pharmaceutical, Inc. Sell -3.42% 2.48%
CHRS Coherus BioSciences, Inc. Sell -3.93% -0.14%
VERU Veru Inc. Sell -3.55% 9.52%
DGX Quest Diagnostics Incorporated Sell -3.91% 0.4%
ALGN Align Technology, Inc. Sell -3.77% 1.08%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
ARDX Sell All 0.83%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.36% -2.81%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.5% -0.67%
VCEL Vericel Corporation Buy 6.85% 4.63%
VREX Varex Imaging Corporation Buy 6.63% 8.51%
AXSM Axsome Therapeutics, Inc. Buy 5.83% -4.63%
NUTX Nutex Health Inc. Buy 5.44% -10.19%
PTCT PTC Therapeutics, Inc. Buy 6.16% 1.53%
CDMO Avid Bioservices, Inc. Buy 4.86% -3.86%
VKTX Viking Therapeutics, Inc. Buy 6.2% -0.93%
IBRX ImmunityBio, Inc. Buy 7.75% 23.75%
HCSG Healthcare Services Group, Inc. Buy 10.11% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 9.55% -5.35%
NEOG Neogen Corporation Buy 8.88% -0.42%
NVRO Nevro Corp. Buy 9.38% 2.04%
INCY Incyte Corporation Buy 9.21% 0.26%
ATEC Alphatec Holdings, Inc. Buy 9.14% 0%
AVXL Anavex Life Sciences Corp. Buy 9.14% 0%
BHVN Biohaven Ltd. Sell -3.64% 3.32%
EVH Evolent Health, Inc. Sell -3.54% -0.69%
SMTI Sanara MedTech Inc. Sell -3.77% -4.6%
COLL Collegium Pharmaceutical, Inc. Sell -3.58% 0.5%
CHRS Coherus BioSciences, Inc. Sell -4.16% -3.19%
VERU Veru Inc. Sell -3.64% 9.52%
DGX Quest Diagnostics Incorporated Sell -4% 0.7%
ALGN Align Technology, Inc. Sell -3.8% 2.76%
The percentage of cash held in the portfolio is: 2.14%
New Assets Added
  • ATEC
  • AVXL
Assets Removed
None
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.27% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.55% 1.81%
VCEL Vericel Corporation Buy 6.96% 8.2%
VREX Varex Imaging Corporation Buy 6.62% 10.33%
AXSM Axsome Therapeutics, Inc. Buy 5.75% -4.17%
NUTX Nutex Health Inc. Buy 5.65% -5.16%
PTCT PTC Therapeutics, Inc. Buy 6.16% 3.41%
CDMO Avid Bioservices, Inc. Buy 4.87% -2.03%
VKTX Viking Therapeutics, Inc. Buy 6.02% -2.01%
IBRX ImmunityBio, Inc. Buy 8.23% 33.97%
HCSG Healthcare Services Group, Inc. Buy 10% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 9.92% 0.09%
NEOG Neogen Corporation Buy 8.9% 1.6%
NVRO Nevro Corp. Buy 9.02% 0%
INCY Incyte Corporation Buy 9.02% 0%
BHVN Biohaven Ltd. Sell -3.62% 1.96%
EVH Evolent Health, Inc. Sell -3.6% -4.1%
SMTI Sanara MedTech Inc. Sell -3.67% -3.8%
COLL Collegium Pharmaceutical, Inc. Sell -3.57% -1.05%
CHRS Coherus BioSciences, Inc. Sell -4.11% -3.88%
VERU Veru Inc. Sell -3.63% 8.33%
DGX Quest Diagnostics Incorporated Sell -3.96% -0.01%
ALGN Align Technology, Inc. Sell -3.84% 0%
The percentage of cash held in the portfolio is: 20.05%
New Assets Added
  • ALGN
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.4% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.64% 3.2%
VCEL Vericel Corporation Buy 7% 8.89%
VREX Varex Imaging Corporation Buy 6.6% 10%
AXSM Axsome Therapeutics, Inc. Buy 5.81% -3.21%
NUTX Nutex Health Inc. Buy 5.3% -10.96%
PTCT PTC Therapeutics, Inc. Buy 6.44% 8.09%
CDMO Avid Bioservices, Inc. Buy 4.88% -1.74%
ALGN Align Technology, Inc. Buy 6.04% -1.68%
VKTX Viking Therapeutics, Inc. Buy 6.16% 0.18%
IBRX ImmunityBio, Inc. Buy 8.19% 33.25%
HCSG Healthcare Services Group, Inc. Buy 9.98% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 9.72% -1.99%
NEOG Neogen Corporation Buy 8.76% 0%
BHVN Biohaven Ltd. Sell -3.66% 1.01%
EVH Evolent Health, Inc. Sell -3.47% -0.34%
SMTI Sanara MedTech Inc. Sell -3.63% -2.69%
COLL Collegium Pharmaceutical, Inc. Sell -3.63% -2.71%
CHRS Coherus BioSciences, Inc. Sell -4.07% -2.91%
VERU Veru Inc. Sell -3.77% 4.76%
DGX Quest Diagnostics Incorporated Sell -3.96% -0.03%
The percentage of cash held in the portfolio is: 28.27%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.21% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.62% 4.24%
VCEL Vericel Corporation Buy 6.89% 8.48%
VREX Varex Imaging Corporation Buy 6.44% 8.68%
NKTR Nektar Therapeutics Buy 5.56% -6.21%
AXSM Axsome Therapeutics, Inc. Buy 5.72% -3.47%
NUTX Nutex Health Inc. Buy 5.69% -3.3%
PTCT PTC Therapeutics, Inc. Buy 6.06% 2.95%
CDMO Avid Bioservices, Inc. Buy 4.78% -2.51%
ALGN Align Technology, Inc. Buy 6.06% -0.29%
VKTX Viking Therapeutics, Inc. Buy 6.18% 1.78%
IBRX ImmunityBio, Inc. Buy 8.9% 46.56%
HCSG Healthcare Services Group, Inc. Buy 9.8% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 9.8% 0%
BHVN Biohaven Ltd. Sell -3.67% -0.54%
EVH Evolent Health, Inc. Sell -3.48% -1.81%
SMTI Sanara MedTech Inc. Sell -3.64% -4.15%
COLL Collegium Pharmaceutical, Inc. Sell -3.58% -2.39%
CHRS Coherus BioSciences, Inc. Sell -3.91% 0%
VERU Veru Inc. Sell -3.91% 0%
DGX Quest Diagnostics Incorporated Sell -3.91% 0%
The percentage of cash held in the portfolio is: 31.39%
New Assets Added
  • CHRS
  • VERU
  • DGX
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 6.39% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.95% 3.82%
VCEL Vericel Corporation Buy 6.95% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 10.34% 54.64%
VREX Varex Imaging Corporation Buy 6.66% 6.69%
NKTR Nektar Therapeutics Buy 5.68% -8.97%
AXSM Axsome Therapeutics, Inc. Buy 6.01% -3.73%
NUTX Nutex Health Inc. Buy 6.06% -2.14%
PTCT PTC Therapeutics, Inc. Buy 6.42% 3.64%
CDMO Avid Bioservices, Inc. Buy 4.99% -3.47%
ALGN Align Technology, Inc. Buy 6.48% 1.33%
VKTX Viking Therapeutics, Inc. Buy 6.81% 6.57%
IBRX ImmunityBio, Inc. Buy 8.08% 26.37%
BHVN Biohaven Ltd. Sell -3.95% -2.66%
EVH Evolent Health, Inc. Sell -3.72% -3.58%
SMTI Sanara MedTech Inc. Sell -3.7% -0.48%
COLL Collegium Pharmaceutical, Inc. Sell -3.72% -1.14%
The percentage of cash held in the portfolio is: 27.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 6.36% -6.82%
ARDX Ardelyx, Inc. Buy 6.6% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7% 2.94%
VCEL Vericel Corporation Buy 6.93% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 10.45% 53.61%
VREX Varex Imaging Corporation Buy 6.72% 5.95%
NKTR Nektar Therapeutics Buy 5.91% -6.9%
AXSM Axsome Therapeutics, Inc. Buy 6.04% -4.84%
NUTX Nutex Health Inc. Buy 6.24% -0.97%
PTCT PTC Therapeutics, Inc. Buy 6.63% 5.29%
CDMO Avid Bioservices, Inc. Buy 5.18% -1.45%
ALGN Align Technology, Inc. Buy 6.5% 0%
VKTX Viking Therapeutics, Inc. Buy 6.5% 0%
IBRX ImmunityBio, Inc. Buy 6.5% 0%
BHVN Biohaven Ltd. Sell -3.98% -1.73%
EVH Evolent Health, Inc. Sell -3.59% 1.81%
SMTI Sanara MedTech Inc. Sell -3.74% 0%
COLL Collegium Pharmaceutical, Inc. Sell -3.74% 0%
The percentage of cash held in the portfolio is: 21.5%
New Assets Added
  • SMTI
  • COLL
  • ALGN
  • VKTX
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 6.38% -6.17%
ARDX Ardelyx, Inc. Buy 6.25% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.96% 2.89%
VCEL Vericel Corporation Buy 6.8% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 10.74% 58.76%
VREX Varex Imaging Corporation Buy 6.65% 5.37%
NKTR Nektar Therapeutics Buy 6.14% -2.76%
AXSM Axsome Therapeutics, Inc. Buy 6.25% -1.1%
NUTX Nutex Health Inc. Buy 5.96% -4.88%
PTCT PTC Therapeutics, Inc. Buy 6.77% 8.04%
CDMO Avid Bioservices, Inc. Buy 5.23% 0%
BHVN Biohaven Ltd. Sell -3.99% -2.49%
EVH Evolent Health, Inc. Sell -3.51% 3.41%
The percentage of cash held in the portfolio is: 33.36%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CUTR Buy All 12%
FATE Buy All 5.61%
IRWD Sell All -6.57%
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.16% -4.23%
ORGO Organogenesis Holdings Inc. Buy 6.95% 0.65%
ARDX Ardelyx, Inc. Buy 6.58% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.24% 5.27%
VCEL Vericel Corporation Buy 6.83% -0.62%
CDXS Codexis, Inc. Buy 6.69% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 8.57% 24.74%
VREX Varex Imaging Corporation Buy 6.65% 3.64%
NKTR Nektar Therapeutics Buy 6.37% -0.69%
AXSM Axsome Therapeutics, Inc. Buy 6.35% -1.02%
NUTX Nutex Health Inc. Buy 6.36% 0%
PTCT PTC Therapeutics, Inc. Buy 6.36% 0%
CUTR Cutera, Inc. Sell -3.5% 6.8%
FATE Fate Therapeutics, Inc. Sell -3.73% 0.62%
BHVN Biohaven Ltd. Sell -4.04% -2.29%
EVH Evolent Health, Inc. Sell -3.66% 0.99%
The percentage of cash held in the portfolio is: 33.82%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.4% -1.64%
ORGO Organogenesis Holdings Inc. Buy 7.05% 0.97%
ARDX Ardelyx, Inc. Buy 6.77% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.36% 5.84%
VCEL Vericel Corporation Buy 6.81% -2.16%
CDXS Codexis, Inc. Buy 6.75% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 6.53% -6.19%
VREX Varex Imaging Corporation Buy 6.76% 4.13%
NKTR Nektar Therapeutics Buy 6.22% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.3% -2.99%
AXSM Axsome Therapeutics, Inc. Buy 6.36% -1.98%
CUTR Cutera, Inc. Sell -3.55% 6.67%
FATE Fate Therapeutics, Inc. Sell -3.73% 1.87%
IRTC iRhythm Technologies, Inc. Sell -3.78% 0.97%
BHVN Biohaven Ltd. Sell -3.99% 0.25%
EVH Evolent Health, Inc. Sell -3.74% 0%
The percentage of cash held in the portfolio is: 45.45%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.69% 4.23%
ORGO Organogenesis Holdings Inc. Buy 6.87% -0.32%
ARDX Ardelyx, Inc. Buy 6.62% -3.48%
BKD Brookdale Senior Living Inc. Buy 7.5% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.38% 7.64%
VCEL Vericel Corporation Buy 6.63% -3.37%
CDXS Codexis, Inc. Buy 6.82% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 6.65% -3.09%
VREX Varex Imaging Corporation Buy 6.4% 0%
NKTR Nektar Therapeutics Buy 6.4% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.4% 0%
AXSM Axsome Therapeutics, Inc. Buy 6.4% 0%
CUTR Cutera, Inc. Sell -3.3% 12%
FATE Fate Therapeutics, Inc. Sell -3.76% -0.31%
IRTC iRhythm Technologies, Inc. Sell -3.75% 0.35%
BHVN Biohaven Ltd. Sell -3.96% -0.33%
The percentage of cash held in the portfolio is: 34%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.66% 5.63%
ORGO Organogenesis Holdings Inc. Buy 7.14% 5.52%
ARDX Ardelyx, Inc. Buy 6.53% -3.15%
BKD Brookdale Senior Living Inc. Buy 7.44% 10.41%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 7.35% 8.99%
VCEL Vericel Corporation Buy 6.61% -1.95%
RDNT RadNet, Inc. Buy 6.72% -0.34%
CDXS Codexis, Inc. Buy 7% 3.83%
SGMO Sangamo Therapeutics, Inc. Buy 6.89% 2.27%
CUTR Cutera, Inc. Sell -3.34% 9.25%
FATE Fate Therapeutics, Inc. Sell -3.68% 0%
IRTC iRhythm Technologies, Inc. Sell -3.64% 1.5%
AXSM Axsome Therapeutics, Inc. Sell -3.84% -3.9%
BHVN Biohaven Ltd. Sell -3.87% 0%
The percentage of cash held in the portfolio is: 56.03%
New Assets Added
  • BHVN
Assets Removed
Asset Action Perf %
ORMP Buy All -1.67%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.57% 3.05%
ORGO Organogenesis Holdings Inc. Buy 7.1% 3.9%
ARDX Ardelyx, Inc. Buy 6.73% -1.16%
BKD Brookdale Senior Living Inc. Buy 6.83% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.99% 2.69%
VCEL Vericel Corporation Buy 6.79% -0.33%
RDNT RadNet, Inc. Buy 6.82% 0.2%
CDXS Codexis, Inc. Buy 6.81% 0%
SGMO Sangamo Therapeutics, Inc. Buy 6.81% 0%
CUTR Cutera, Inc. Sell -3.42% 8%
FATE Fate Therapeutics, Inc. Sell -3.53% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.66% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.58% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -3.73% 0.18%
The percentage of cash held in the portfolio is: 56.47%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.45% 0.7%
ORGO Organogenesis Holdings Inc. Buy 6.9% 0.32%
ARDX Ardelyx, Inc. Buy 6.79% -0.83%
BKD Brookdale Senior Living Inc. Buy 6.85% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 6.85% 0%
VCEL Vericel Corporation Buy 6.85% 0%
RDNT RadNet, Inc. Buy 6.85% 0%
CUTR Cutera, Inc. Sell -3.54% 5.33%
FATE Fate Therapeutics, Inc. Sell -3.55% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -3.72% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.47% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -3.7% 1.35%
The percentage of cash held in the portfolio is: 70.46%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.43% 0%
ORGO Organogenesis Holdings Inc. Buy 6.88% -0.32%
ARDX Ardelyx, Inc. Buy 6.87% 0%
CUTR Cutera, Inc. Sell -3.8% -1.33%
FATE Fate Therapeutics, Inc. Sell -3.61% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -3.74% 0.42%
IRTC iRhythm Technologies, Inc. Sell -3.43% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -3.81% -1.12%
The percentage of cash held in the portfolio is: 98.21%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.34% -1.17%
ORGO Organogenesis Holdings Inc. Buy 6.75% -1.95%
CUTR Cutera, Inc. Sell -3.64% 2.67%
FATE Fate Therapeutics, Inc. Sell -3.43% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -3.76% -0.42%
IRTC iRhythm Technologies, Inc. Sell -3.44% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -3.61% 4.05%
The percentage of cash held in the portfolio is: 104.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.48% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 6.89% 0%
ORGO Organogenesis Holdings Inc. Buy 6.89% 0%
CUTR Cutera, Inc. Sell -3.75% 0%
FATE Fate Therapeutics, Inc. Sell -3.76% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -3.68% 1.67%
IRTC iRhythm Technologies, Inc. Sell -3.76% 0%
AXSM Axsome Therapeutics, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 98.45%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 6.43% 0%
CUTR Cutera, Inc. Sell -3.75% 0%
FATE Fate Therapeutics, Inc. Sell -3.75% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 104.82%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Buy All 16.11%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 7.18% -8.98%
CERS Cerus Corporation Sell -3.46% 14.69%
The percentage of cash held in the portfolio is: 96.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 7.57% -3.32%
MYGN Myriad Genetics, Inc. Buy 7.61% 2.48%
CERS Cerus Corporation Sell -3.43% 14.69%
The percentage of cash held in the portfolio is: 88.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -8.2%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 8.54% -4.92%
NVCR NovoCure Limited Buy 7.59% -2.44%
MYGN Myriad Genetics, Inc. Buy 7.79% 5.56%
CERS Cerus Corporation Sell -3.38% 15.64%
The percentage of cash held in the portfolio is: 79.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
LMAT Buy All 0.21%
AVXL Buy All 6.46%
PODD Sell All 15.5%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.83% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -2.73%
NVCR NovoCure Limited Buy 7.77% -0.17%
MYGN Myriad Genetics, Inc. Buy 7.82% 6.04%
LMAT LeMaitre Vascular, Inc. Sell -3.72% 0.25%
AVXL Anavex Life Sciences Corp. Sell -3.47% 7.14%
CERS Cerus Corporation Sell -3.73% 6.64%
The percentage of cash held in the portfolio is: 76.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 0.59%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.82% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.69% -3.83%
NVCR NovoCure Limited Buy 7.79% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.68% 3.45%
STAA STAAR Surgical Company Sell -3.7% 3.06%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.08%
AVXL Anavex Life Sciences Corp. Sell -3.64% 3.06%
CERS Cerus Corporation Sell -3.93% 2.37%
The percentage of cash held in the portfolio is: 81.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.31% 1.14%
PODD Insulet Corporation Buy 9.82% 12.73%
MGNX MacroGenics, Inc. Buy 9.43% 2.85%
ESPR Esperion Therapeutics, Inc. Buy 8.77% -4.37%
TVTX Travere Therapeutics, Inc. Buy 9.26% 31.25%
NVCR NovoCure Limited Buy 7.63% -3.99%
MYGN Myriad Genetics, Inc. Buy 7.37% -2.15%
STAA STAAR Surgical Company Sell -3.58% 7.41%
LMAT LeMaitre Vascular, Inc. Sell -3.77% 0.97%
AVXL Anavex Life Sciences Corp. Sell -3.38% 11.39%
CERS Cerus Corporation Sell -3.95% 3.32%
The percentage of cash held in the portfolio is: 56.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.13% 3.11%
AADI Aadi Bioscience, Inc. Buy 6.59% 5.14%
PODD Insulet Corporation Buy 9.75% 11.4%
MGNX MacroGenics, Inc. Buy 9.5% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.76% -4.92%
TVTX Travere Therapeutics, Inc. Buy 9.04% 27.5%
NVCR NovoCure Limited Buy 7.62% -4.54%
MYGN Myriad Genetics, Inc. Buy 7.38% -2.56%
STAA STAAR Surgical Company Sell -3.64% 6.36%
LMAT LeMaitre Vascular, Inc. Sell -3.73% 2.57%
AVXL Anavex Life Sciences Corp. Sell -3.34% 12.76%
CERS Cerus Corporation Sell -3.99% 2.84%
The percentage of cash held in the portfolio is: 49.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.84% -1.69%
AGEN Agenus Inc. Buy 5.93% -0.18%
AADI Aadi Bioscience, Inc. Buy 6.37% 1.71%
PODD Insulet Corporation Buy 9.69% 10.8%
MGNX MacroGenics, Inc. Buy 9.34% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.7% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.47% 33.75%
NVCR NovoCure Limited Buy 7.47% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.58% 0.26%
STAA STAAR Surgical Company Sell -3.62% 6.89%
LMAT LeMaitre Vascular, Inc. Sell -3.71% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.26% 14.88%
VREX Varex Imaging Corporation Sell -3.98% 2.99%
CERS Cerus Corporation Sell -3.98% 2.84%
The percentage of cash held in the portfolio is: 48.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 0.85%
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.93% 0.21%
CARA Cara Therapeutics, Inc. Buy 5.35% -9.62%
AGEN Agenus Inc. Buy 5.55% -6.22%
AADI Aadi Bioscience, Inc. Buy 6.45% 3.43%
PODD Insulet Corporation Buy 9.33% 7.2%
MGNX MacroGenics, Inc. Buy 9.01% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.51% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.45% 33.96%
NVCR NovoCure Limited Buy 7.3% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.58% 0.63%
CDMO Avid Bioservices, Inc. Sell -3.28% 15.41%
STAA STAAR Surgical Company Sell -3.59% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.7% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.34% 12.41%
VREX Varex Imaging Corporation Sell -3.57% 12.56%
CERS Cerus Corporation Sell -3.91% 4.27%
The percentage of cash held in the portfolio is: 46.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.22% 3%
CARA Cara Therapeutics, Inc. Buy 5.67% -6.12%
AGEN Agenus Inc. Buy 5.47% -9.51%
AADI Aadi Bioscience, Inc. Buy 6.66% 4.57%
PODD Insulet Corporation Buy 9.34% 5.05%
MGNX MacroGenics, Inc. Buy 8.67% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.44% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.24% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.89% -3.01%
NVCR NovoCure Limited Buy 7.58% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.69% 0%
CDMO Avid Bioservices, Inc. Sell -3.3% 16.54%
STAA STAAR Surgical Company Sell -3.8% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.85% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.41% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.55% -17.04%
BGNE BeiGene, Ltd. Sell -3.28% 0.24%
VREX Varex Imaging Corporation Sell -4.11% 1.28%
CERS Cerus Corporation Sell -3.99% 4.27%
The percentage of cash held in the portfolio is: 48.43%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.91% -1.42%
ORGO Organogenesis Holdings Inc. Buy 5.6% -6.71%
CARA Cara Therapeutics, Inc. Buy 5.62% -6.41%
AGEN Agenus Inc. Buy 5.48% -8.59%
AADI Aadi Bioscience, Inc. Buy 6.51% 2.86%
PODD Insulet Corporation Buy 9.34% 5.72%
MGNX MacroGenics, Inc. Buy 8.95% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.74% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.4% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 8.08% 0%
NVCR NovoCure Limited Buy 8.05% 0%
CDMO Avid Bioservices, Inc. Sell -3.34% 14.93%
STAA STAAR Surgical Company Sell -3.78% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.82% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.65% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.01% -3.7%
BGNE BeiGene, Ltd. Sell -3.26% 0.1%
VREX Varex Imaging Corporation Sell -4.24% -2.31%
CERS Cerus Corporation Sell -4.08% 1.42%
The percentage of cash held in the portfolio is: 50.51%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -5.21%
ORGO Organogenesis Holdings Inc. Buy 5.71% -4.59%
CARA Cara Therapeutics, Inc. Buy 5.62% -6.12%
AGEN Agenus Inc. Buy 5.31% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.49% 2.86%
PODD Insulet Corporation Buy 9.17% 3.96%
MGNX MacroGenics, Inc. Buy 8.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.23% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.48% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 8.07% 0%
CDMO Avid Bioservices, Inc. Sell -3.42% 12.67%
STAA STAAR Surgical Company Sell -3.81% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.69% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.77% 2.22%
BGNE BeiGene, Ltd. Sell -3.21% 1.63%
VREX Varex Imaging Corporation Sell -4.13% 0%
CERS Cerus Corporation Sell -4.13% 0%
The percentage of cash held in the portfolio is: 58.46%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.79% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.8% -3.5%
AGEN Agenus Inc. Buy 5.43% -9.51%
CERS Cerus Corporation Buy 5.82% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.29% -0.57%
PODD Insulet Corporation Buy 8.94% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -10.38%
MGNX MacroGenics, Inc. Buy 8.7% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.31% 0%
TVTX Travere Therapeutics, Inc. Buy 7.16% 0%
CDMO Avid Bioservices, Inc. Sell -3.62% 8.03%
STAA STAAR Surgical Company Sell -3.92% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.8% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.59% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.84% 0.74%
BGNE BeiGene, Ltd. Sell -3.21% 1.84%
The percentage of cash held in the portfolio is: 44.96%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.92% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.11% 4.96%
AGEN Agenus Inc. Buy 5.48% -5.85%
CERS Cerus Corporation Buy 5.82% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.34% 3.43%
NEOG Neogen Corporation Buy 6.92% 0.35%
PODD Insulet Corporation Buy 8.5% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.47% -1.15%
MGNX MacroGenics, Inc. Buy 9.02% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.02% 0%
CDMO Avid Bioservices, Inc. Sell -3.8% 0.38%
STAA STAAR Surgical Company Sell -3.89% -2.22%
PINC Premier, Inc. Sell -3.92% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% -2.38%
VERU Veru Inc. Sell -3.79% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.8% -1.48%
BGNE BeiGene, Ltd. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 47.08%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.58% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.04% 3.79%
AGEN Agenus Inc. Buy 5.44% -6.58%
CERS Cerus Corporation Buy 5.78% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.89% -4%
NEOG Neogen Corporation Buy 6.75% -2.15%
PODD Insulet Corporation Buy 8.57% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.57% 0%
CDMO Avid Bioservices, Inc. Sell -3.68% 3.4%
STAA STAAR Surgical Company Sell -3.75% 1.42%
PINC Premier, Inc. Sell -3.82% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.75% 0%
AVXL Anavex Life Sciences Corp. Sell -3.75% 0%
VERU Veru Inc. Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.98% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.02% 4.66%
AGEN Agenus Inc. Buy 5.92% 2.93%
CERS Cerus Corporation Buy 5.91% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.82% -4%
NEOG Neogen Corporation Buy 6.82% 0%
CDMO Avid Bioservices, Inc. Sell -3.66% 2.74%
STAA STAAR Surgical Company Sell -3.76% 0%
PINC Premier, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 63.38%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.09% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.14% 7.87%
AGEN Agenus Inc. Buy 6.11% 7.31%
CERS Cerus Corporation Buy 6% 0%
AADI Aadi Bioscience, Inc. Buy 6% 0%
CDMO Avid Bioservices, Inc. Sell -3.65% 2.08%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.71% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0.64%
ORGO Organogenesis Holdings Inc. Buy 5.93% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.81% 1.46%
AGEN Agenus Inc. Buy 6.07% 6.03%
CDMO Avid Bioservices, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 74.46%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings